Davis's Drug Guide
nirsevimab
General
Pronunciation:
nir-sev-i-mab
Trade Name(s)
- Beyfortus
Ther. Class.
Pharm. Class.
monoclonal antibodies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Nirsevimab." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580070/all/nirsevimab.
Vallerand AHA, Sanoski CAC. Nirsevimab. Davis's Drug Guide. F.A. Davis Company; 2026. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580070/all/nirsevimab. Accessed June 26, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Nirsevimab. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580070/all/nirsevimab
Vallerand AHA, Sanoski CAC. Nirsevimab [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 26]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580070/all/nirsevimab.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - nirsevimab
ID - 3580070
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/3580070/all/nirsevimab
PB - F.A. Davis Company
ET - 20
DB - Anesthesia Central
DP - Unbound Medicine
ER -
